These findings were of great interest in that fenofibrate treatment completely restored the suppressed expression of PPARα associated with decreases of the FFA and TG concentrations in the kidneys which were significantly increased owing to diabetes (Fig. 2J–L, P<0.05, respectively). Here, PPARA is linked to diabetes mellitus.